Hospital-based clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013

Eurosurveillance

Volumn 20, Issue 38, 2015, Pages

  Pituch, Hanna ^a   Obuch Woszczatynski P ^a   Lachowicz, D ^a   Wultanska D ^a   Karpinski P ^a   Mlynarczyk G ^a   van Dorp, S M ^b   Kuijper, E J ^b   Schneider, Anna ^c   Nurzyńska, Grażyna ^a   Szulencka, Grażyna ^d   Mikucka, Agnieszka ^e   Kędzierska, Jolanta ^f   Guzek, Aneta ^g   Pawlik, Danuta ^h   Dubiel, Grzegorz ⁱ   Sztych, Katarzyna ^j   Waker, Edyta ^k   Hass, Katarzyna ^k   Kostkiewicz, Marek ^l   Bilska, Iwona ^m   Musz Kawecka, Marta ⁿ   more..

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c 1st Department of Cardiology   (Poland)

^d Provincial Hospital   (Poland)

^e NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^f UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^g MILITARY INSTITUTE OF MEDICINE   (Poland)

^h Provincial Hospital   (Poland)

ⁱ Center of Pulmonology and Thoracic Surgery in Bystra   (Poland)

^j Provincial Hospital   (Poland)

^k INSTITUTE OF ONCOLOGY   (Poland)

^l Voivodship Hospital   (Poland)

^m POMERANIAN MEDICAL UNIVERSITY   (Poland)

ⁿ Medical Center in a cut   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL DECISION MAKING; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; HOSPITAL BED; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MOLECULAR GENETICS; MORBIDITY; PATIENT SELECTION; POLAND; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RIBOTYPING; TOXICITY; AGED; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FECES; FEMALE; GENETICS; HEALTH SURVEY; HOSPITAL LABORATORY; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; STATISTICS AND NUMERICAL DATA;

BACTERIAL TOXIN;

AGED; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; FECES; FEMALE; HUMANS; INCIDENCE; LABORATORIES, HOSPITAL; MALE; MIDDLE AGED; POLAND; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RIBOTYPING;

EID: 85000763508     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.38.30025     Document Type: Article

References (27)

1. Peniche AG, Savidge TC, Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis. 2013; 26(5): 447-53. DOI: 10. 1097/01. qco. 0000433318. 82618. c6 PMID: 23982235
2. Muto CA, Blank MK, Marsh JW, Vergis EN, O'Leary MM, Shutt KA, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis. 2007; 45(10): 1266-73. DOI: 10. 1086/522654 PMID: 17968819
3. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005; 353(23): 2433-41. DOI: 10. 1056/NEJMoa051590 PMID: 16322603
4. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353(23): 2442-9. DOI: 10. 1056/NEJMoa051639 PMID: 16322602
5. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006; 145(10): 758-64. DOI: 10. 7326/0003-4819-145-10-200611210-00008 PMID: 17116920
6. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005; 366(9491): 1079-84. DOI: 10. 1016/ S0140-6736(05)67420-X PMID: 16182895
7. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill. 2008; 13(31): 18942. PMID: 18761903
8. Birgand G, Blanckaert K, Carbonne A, Coignard B, Barbut F, Eckert C, et al. Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, 2006-2007 and associated clusters in 2008-2009. Euro Surveill. 2010; 15(25): 19597. PMID: 20587362
9. Kuijper EJ, van den Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A, et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis. 2006; 12(5): 827-30. DOI: 10. 3201/eid1205. 051350 PMID: 16704846
10. Smith A. Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill. 2005; 10(26): 2735. PMID: 16783109
11. Starzengruber P, Segagni Lusignani L, Wrba T, Mitteregger D, Indra A, Graninger W, et al. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Wien Klin Wochenschr. 2014; 126(13-14): 427-30. DOI: 10. 1007/s00508-014-0549-x PMID: 24903143
12. Oleastro M, Coelho M, Giao M, Coutinho S, Mota S, Santos A, et al. Outbreak of Clostridium difficile PCR ribotype 027--the recent experience of a regional hospital. BMC Infect Dis. 2014; 14(1): 209. DOI: 10. 1186/1471-2334-14-209 PMID: 24739945
13. Rafila A, Indra A, Popescu GA, Wewalka G, Allerberger F, Benea S, et al. Occurrence of Clostridium difficile infections due to PCR ribotype 027 in Bucharest, Romania. J Infect Dev Ctries. 2014; 8(6): 694-8. DOI: 10. 3855/jidc. 4435 PMID: 24916866
14. Popescu GA, Florea D, Rafila A. Clostridium difficile is emerging in Romania: a story of 027 ribotype and excessive antibiotic consumption. J Gastrointestin Liver Dis. 2014; 23(3): 342-3. PMID: 25267968
15. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet. 2013; 45(1): 109-13. DOI: 10. 1038/ng. 2478 PMID: 23222960
16. Pituch H, Bakker D, Kuijper E, Obuch-Woszczatyński P, Wultańska D, Nurzyńska G, et al. First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland. Pol J Microbiol. 2008; 57(3): 267-8. PMID: 19004250
17. Nyč O, Pituch H, Matějkova J, Obuch-Woszczatynski P, Kuijper EJ. Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet. 2011; 377(9775): 1407. DOI: 10. 1016/S0140-6736(11)60575-8 PMID: 21515161
18. Obuch-Woszczatyński P, Lachowicz D, Schneider A, Mol A, Pawłowska J, Ożdżeńska-Milke E, et al. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010. Anaerobe. 2014; 28: 13-7. DOI: 10. 1016/j. anaerobe. 2014. 04. 007 PMID: 24799338
19. ESCMID Study Group for Clostridium difficile EU Member States European Centre for Disease Prevention and Control, Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006; 12(6) Suppl 6; 2-18. DOI: 10. 1111/j. 1469-0691. 2006. 01580. x PMID: 16965399
20. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol. 1999; 37(2): 461-3. PMID: 9889244
21. Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014; 14(12): 1208-19. DOI: 10. 1016/S1473-3099(14)70991-0 PMID: 25455988
22. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotypingbased surveillance scheme in England. Clin Infect Dis. 2012; 55(8): 1056-63. DOI: 10. 1093/cid/cis614 PMID: 22784871
23. ECDIS Study Group, Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011; 377(9759): 63-73. DOI: 10. 1016/S0140-6736(10)61266-4 PMID: 21084111
24. Van Dorp SM, Kola A, Behnke M, Gastmeier P, Schmid D, Hajdu A, et al. C. difficile infections in acute care hospitals-results of the pilot study of a European surveillance initiative. Poster presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 2014 May 10-13; Barcelona.
25. Clostridium difficile study group Hesse, Arvand M, Vollandt D, Bettge-Weller G, Harmanus C, Kuijper EJ, the Clostridium difficile study groC. Increased incidence of Clostridium difficile PCR ribotype 027 in Hesse, Germany, 2011 to 2013. Euro Surveill. 2014; 19(10): 20732. DOI: 10. 2807/1560-7917. ES2014. 19. 10. 20732 PMID: 24650866
26. Krutova M, Nyc O, Kuijper EJ, Geigerova L, Matejkova J, Bergerova T, et al. A case of imported Clostridium difficile PCR-ribotype 027 infection within the Czech Republic which has a high prevalence of C. difficile ribotype 176. Anaerobe. 2014; 30: 153-5. DOI: 10. 1016/j. anaerobe. 2014. 09. 020 PMID: 25300750
27. Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol. 2010; 48(8): 2892-6. DOI: 10. 1128/JCM. 02482-09 PMID: 20554809